Etel Rodrigues Pereira Gimba (Etel R P Gimba)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Cell Cycle Arrest

Radical Prostatectomy

Ischemia Reperfusion Injury

Top Venues

Molecular biology reports

Clinical and translational science

Oxidative medicine and cellular longevity

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriela Ribeiro Silva, Luciana Bueno Ferreira, Etel Rodrigues Pereira Gimba
Expression and prognostic potential of osteopontin splice variants in malignant melanoma. Clinical and translational science 17 (8) (2024)
Gabriela Ribeiro Silva, Luciana Bueno Ferreira, Etel Rodrigues Pereira Gimba
Expression and prognostic potential of osteopontin splice variants in malignant melanoma. Clinical and translational science 17 (8) (2024)
Vanessa P Rocha, Samir P C Campos, Caroline A Barros, Pablo Trindade, Leticia R Q Souza, Triciana G Silva, Etel Rodrigues Pereira Gimba, Anderson Junger Teodoro, Rafael Braga Gonçalves
Bovine Lactoferrin Induces Cell Death in Human Prostate Cancer Cells. Oxidative medicine and cellular longevity 2022 (2022)
Paula Priscilla de Freitas, Ruan Carlos Busquet Ribeiro, Isabella Dos Santos Guimarães, Caroline S Moreira, David R Rocha, Fernando de Carvalho da Silva, Vitor Francisco Ferreira, Etel Rodrigues Pereira Gimba
(3,3'-Methylene)bis-2-hydroxy-1,4-naphthoquinones induce cytotoxicity against DU145 and PC3 cancer cells by inhibiting cell viability and promoting cell cycle arrest. Molecular biology reports 48 (4) (2021)
Ana Emília Goulart Lemos, Gabriela Ribeiro Silva, Etel Rodrigues Pereira Gimba, Aline da Rocha Matos
Susceptibility of lung cancer patients to COVID-19: A review of the pandemic data from multiple nationalities. Thoracic cancer 12 (20) (2021)
Gabriela Ribeiro Silva, Daniella Santos Mattos, Ana Clara Santos da Fonseca Bastos, Bruna Prunes Pena Baroni Viana, Mariana Concentino Menezes Brum, Luciana Bueno Ferreira, Etel Rodrigues Pereira Gimba
Osteopontin-4 and Osteopontin-5 splice variants are expressed in several tumor cell lines. Molecular biology reports 47 (10) (2020)
Júlio C Santoro, Ana C S F Bastos, Etel Rodrigues Pereira Gimba, Mariana Emerenciano
Reinforcing osteopontin as a marker of central nervous system relapse in paediatric B-cell acute lymphoblastic leukaemia: SPP1 splice variant 3 in the spotlight. British journal of haematology 186 (4) (2019)